Dragonfly Therapeutics Head of Biology Ann Cheung is featured among Endpoints News’ top trailblazers in biopharmaceutical research & development. The profile chronicles her career transitions from her early years as the lone immuno-oncology researcher in the Jacks Lab to her current role moving NK cell therapies from bench to bedside. Longtime Koch Institute member Aviv Regev is also recognized for her groundbreaking work in single cell sequencing, computational biology, and genetics.